Today: 21 May 2026
CrowdStrike stock dips as year-end tech pullback drags cybersecurity names
29 December 2025
1 min read

CrowdStrike stock dips as year-end tech pullback drags cybersecurity names

NEW YORK, December 29, 2025, 13:49 ET — Regular session.

  • CrowdStrike down about 1% in afternoon trading.
  • Palo Alto Networks, Fortinet and Zscaler also lower in a softer tape for cybersecurity.
  • Investors eye Fed minutes and jobless claims in a holiday-shortened week with markets shut Thursday.

CrowdStrike Holdings, Inc. shares fell about 1% on Monday, down $4.77 to $476.42 in afternoon trading.

The move put the cybersecurity firm among the decliners as investors pared exposure to technology shares in the final trading week of 2025 after last week’s rally pushed U.S. indexes to record highs, a Reuters report showed.

Trading is expected to stay thin in the holiday-affected week, with U.S. markets closed on Thursday for New Year’s Day. Minutes from the Federal Reserve’s previous meeting and a weekly reading of jobless claims are among the main macro events on the calendar, Reuters reported.

CrowdStrike traded between $474.64 and $483.10 on the session, after opening at $478.68, market data showed.

Other cybersecurity stocks moved in the same direction. Palo Alto Networks fell 0.9%, Fortinet dropped 1.2% and Zscaler slid 1.1%, while SentinelOne added 0.2%.

At 11:13 a.m. ET, the Nasdaq was down 0.6% and the S&P 500 was off 0.4% as heavyweight tech names retreated, Reuters said.

“This is not the beginning of the end of the tech dominance, it’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Reuters

CrowdStrike sells cloud-based cybersecurity software that protects endpoints — devices such as laptops and servers — as well as cloud workloads. It competes with firms including Palo Alto Networks and Fortinet.

With few CrowdStrike-specific headlines driving trading on Monday, the stock largely tracked moves in the broader software and security group.

The next focal point is the company’s quarterly report, expected around March 3, 2026, according to data published by MLQ.ai, though the company has not confirmed a date. The site lists an analyst EPS estimate of about $1.10 per share, and investors typically focus on annual recurring revenue (ARR) — a subscription metric that tracks the value of contracted, repeatable revenue — and customer retention.

On charts, the $475 area — near Monday’s intraday low — is an early level traders will watch as the holiday week keeps liquidity thin.

Stock Market Today

  • Nvidia (NVDA) Reports Strong Q1 2026 with Revenue Surging 85% and Robust Guidance
    May 20, 2026, 6:31 PM EDT. Nvidia (NASDAQ:NVDA) delivered an 85.2% year-on-year revenue increase to $81.62 billion in Q1 CY2026, beating analyst expectations by 3.5%. Its adjusted earnings per share of $1.87 also surpassed forecasts by 5.4%. The company's non-GAAP EBITDA margin rose to 69.2%, supported by operating margins climbing to 65.6% from 49.1% a year ago. Nvidia provided Q2 revenue guidance of $91 billion, 5.7% above consensus, signaling accelerating demand amid growth in AI infrastructure. CEO Jensen Huang highlighted the rapid expansion of AI factories as a key growth driver. The firm's five-year compounded annual revenue growth rate sits at 67.4%, with recent acceleration reflecting strong market positioning in semiconductors, despite cyclical industry risks.

Latest articles

EnerSys Stock Just Reversed After Earnings—The Guidance Beat Traders Wanted

EnerSys Stock Just Reversed After Earnings—The Guidance Beat Traders Wanted

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award
Previous Story

Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award

Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears
Next Story

Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears

Go toTop